单发2cm以下微血管侵犯肝癌患者的预后生存分析
DOI: 10.3971/j.issn.1000-8578.2015.04.008
Keywords: A Case Report,Correlation of CD68+ Tumor-associated Macrophages Number with Ki-67 Expression and Prognosis of Patients with Primary Hepatocellular Carcinoma,Advance of Immune Checkpoint Inhibitors in Therapy of Liver Cancer,Screening of Genes Involved in Hepatoma Cells SMMC-7721 Stress Response Induced by Different Stressors,Clinical Advances of Molecular-targeted Therapy on Primary Hepatocellular Carcinoma,Association Between Type-2 Diabetes Mellitus and Platelet Count in Patients with Primary Liver Cancers,Situation and Problem on Screening of Liver Cancer in High-incidence Area of Xiaolan, Zhongshan City,Influence of Adriamycin on Human Hepatocellular Carcinoma Cells with Different Metastatic Abilities and Expression of Cancer Stem Cell Related Genes,FAT10-induced Autophagy Regulates Radiosensitivity of Hepatocellular Carcinoma Cells,Comparison of Different Methods of Vascular Occlusion in Hepatectomy on Prognosis of Operable Small Liver Cancer Patients,Construction and Screening of shRNA Expression Plasmids Targeting at cortactin Gene
Abstract:
摘要 目的 2 cm以下的单发肝癌有着良好的术后生存。而微血管侵犯被认为是影响肝癌预后的 独立危险因素，其对单发小肝癌（≤2 cm）的影响尚不清楚。本研究的目的在于研究微血管侵犯对 于2 cm以下单发肝癌预后的影响。方法 回顾性分析云南省肿瘤医院2001年1月至2008年12月间住院 的62例2 cm以下单发肝癌患者的临床及术后病理资料，探讨微血管侵犯对预后的影响。结果 62例2 cm以下单发肝癌患者中，16例有微血管侵犯、46例无微血管侵犯。16例有微血管侵犯的患者，其术 后5年生存率为81.3%，而无微血管侵犯患者的术后5年生存率为93.5%，两者之间差异无统计学意义 （P=0.496）。结论 2 cm以下的单发肝癌有着良好的预后，微血管侵犯不影响2 cm以下单发肝癌的 长期生存；为了确认微血管侵犯是否不影响2 cm以下单发肝癌的长期生存，仍需要多中心大样本的数 据进行进一步验证
Full-Text
